Status:

RECRUITING

Spectroscopic Evaluation of Middle Ear Infection

Lead Sponsor:

University of California, Irvine

Collaborating Sponsors:

National Institute on Deafness and Other Communication Disorders (NIDCD)

Conditions:

Middle Ear Infection

Eligibility:

All Genders

Up to 21 years

Brief Summary

Otitis media is more common in young children and it is estimated that 75% of all children experience at least one episode before the age of three. Otitis media is one of the common pediatric diagnose...

Detailed Description

The research can use low energy LED signal light sent into the ear canal to measure the tissue optical properties including the absorption of the light signal and the amount of signal that will be bac...

Eligibility Criteria

Inclusion

  • Male/ female at all age- newborn to adult.
  • Non- pregnant woman.
  • Diagnose of middle ear infection and plan for surgery procedure.

Exclusion

  • Pregnant woman
  • Incompetent adults (i.e. individuals with cognitive impairment)
  • No diagnose of middle ear infection and no plan for surgery procedure.
  • Adults with cognitive impairment and children of parents that are cognitively impaired and thus are unable to consent will be excluded from the study.

Key Trial Info

Start Date :

February 26 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2028

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04812093

Start Date

February 26 2021

End Date

December 31 2028

Last Update

January 7 2026

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Children's Hospital of Orange County (CHOC)

Orange, California, United States, 92868

2

UCI Otolaryngology Clinic

Orange, California, United States, 92868